Visfatin is involved in the cisplatin resistance of osteosarcoma cells via upregulation of Snail and Zeb1

References

• Anderson ME. Update on survival in osteosarcoma. Orthop Clin North Am. 2016;47:283–292. doi:10.1016/j.ocl.2015.08.022.
   PubMed Web of Science ®Google Scholar
• Kansara M, Teng MW, Smyth MJ, Thomas DM. Translational biology of osteosarcoma. Nat Rev Cancer. 2014;14:722–735. doi:10.1038/nrc3838.
   PubMed Web of Science ®Google Scholar
• Craft AW. Osteosarcoma: the European Osteosarcoma Intergroup (EOI) perspective. Cancer Treat Res. 2009;152:263–274. doi:10.1007/978-1-4419-0284-9_13.
   PubMedGoogle Scholar
• Hattinger CM, Fanelli M, Tavanti E, Vella S, Ferrari S, Picci P, Serra M. Advances in emerging drugs for osteosarcoma. Expert Opin Emerg Drugs. 2015;20:495–514. doi:10.1517/14728214.2015.1051965.
   PubMed Web of Science ®Google Scholar
• Laiguillon MC, Houard X, Bougault C, Gosset M, Nourissat G, Sautet A, Jacques C, Berenbaum F, Sellam J. Expression and function of visfatin (Nampt), an adipokine-enzyme involved in inflammatory pathways of osteoarthritis. Arthritis Res Ther. 2014;16:R38. doi:10.1186/ar4467.
   PubMed Web of Science ®Google Scholar
• Romacho T, Sanchez-Ferrer CF, Peiro C. Visfatin/Nampt: an adipokine with cardiovascular impact. Mediators Inflamm. 2013;2013:946427. doi:10.1155/2013/946427.
   PubMed Web of Science ®Google Scholar
• Carbone F, Liberale L, Bonaventura A, Vecchie A, Casula M, Cea M, Monacelli F, Caffa I, Bruzzone S, Montecucco F, et al. Regulation and function of extracellular nicotinamide phosphoribosyltransferase/visfatin. Compr Physiol. 2017;7:603–621. doi:10.1002/cphy.c160029.
   PubMed Web of Science ®Google Scholar
• Liang N, Chen Y, Yang L, He S, Liu T. Visfatin increases miR-21 to promote migration in HCC. Cell Mol Biol (Noisy-Le-Grand). 2018;64:48–52. doi:10.14715/cmb/2018.64.6.9.
   PubMed Web of Science ®Google Scholar
• Wang G, Tian W, Liu Y, Ju Y, Shen Y, Zhao S, Zhang B, Li Y. Visfatin triggers the cell motility of non-small cell lung cancer via up-regulation of matrix metalloproteinases. Basic Clin Pharmacol Toxicol. 2016;119:548–554. doi:10.1111/bcpt.12623.
   PubMed Web of Science ®Google Scholar
• Yang J, Zhang K, Song H, Wu M, Li J, Yong Z, Jiang S, Kuang X, Zhang T. Visfatin is involved in promotion of colorectal carcinoma malignancy through an inducing EMT mechanism. Oncotarget. 2016;7:32306–32317. doi:10.18632/oncotarget.8615.
   PubMed Web of Science ®Google Scholar
• Wang GJ, Shen NJ, Cheng L, Yehan F, Huang H, Li KH. Visfatin triggers the in vitro migration of osteosarcoma cells via activation of NF-kappaB/IL-6 signals. Eur J Pharmacol. 2016;791:322–330. doi:10.1016/j.ejphar.2016.08.029.
   PubMed Web of Science ®Google Scholar
• Cheng G, Liu C, Sun X, Zhang L, Liu L, Ouyang J, Li B. Visfatin promotes osteosarcoma cell migration and invasion via induction of epithelial-mesenchymal transition. Oncol Rep. 2015;34:987–994. doi:10.3892/or.2015.4053.
   PubMed Web of Science ®Google Scholar
• Cao Z, Liang N, Yang H, Li S. Visfatin mediates doxorubicin resistance in human non-small-cell lung cancer via Akt-mediated up-regulation of ABCC1. Cell Prolif. 2017;50:e12366. doi:10.1111/cpr.12366
   Web of Science ®Google Scholar
• Yan X, Zhao J, Zhang R. Visfatin mediates doxorubicin resistance in human colorectal cancer cells via up regulation of multidrug resistance 1 (MDR1). Cancer Chemother Pharmacol. 2017;80:395–403. doi:10.1007/s00280-017-3365-y.
   PubMed Web of Science ®Google Scholar
• Whelan J, Patterson D, Perisoglou M, Bielack S, Marina N, Smeland S, Bernstein M. The role of interferons in the treatment of osteosarcoma. Pediatr Blood Cancer. 2010;54:350–354. doi:10.1002/pbc.22136.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Ling XL, Li SW, Li XQ, Yan B. Establishment of a human hepatoma multidrug resistant cell line in vitro. World J Gastroenterol. 2010;16:2291–2297.
   PubMed Web of Science ®Google Scholar
• Hamidi A, Song J, Thakur N, Itoh S, Marcusson A, Bergh A, Heldin C-H, Landström M. TGF-beta promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85 alpha. Sci Signal. 2017;10:eaal4186. doi:10.1126/scisignal.aal4186.
   PubMed Web of Science ®Google Scholar
• Jin J, Sun ZJ, Yang F, Tang L, Chen WW, Guan XX. miR-19b-3p inhibits breast cancer cell proliferation and reverses saracatinib-resistance by regulating PI3K/Akt pathway. Arch Biochem Biophys. 2018;645:54–60. doi:10.1016/j.abb.2018.03.015.
   PubMed Web of Science ®Google Scholar
• Zheng HC. The molecular mechanisms of chemoresistance in cancers. Oncotarget. 2017;8:59950–59964. doi:10.18632/oncotarget.19048.
   PubMed Web of Science ®Google Scholar
• Zhu GH, Huang C, Feng ZZ, Lv XH, Qiu ZJ. Hypoxia-induced snail expression through transcriptional regulation by HIF-1 alpha in pancreatic cancer cells. Digest Dis Sci. 2013;58:3503–3515. doi:10.1007/s10620-013-2841-4.
   PubMed Web of Science ®Google Scholar
• Li X, Deng W, Nail CD, Bailey SK, Kraus MH, Ruppert JM, Lobo-Ruppert SM. Snail induction is an early response to Gli1 that determines the effciency of epithelial transformation. Oncogene. 2006;25:609–621. doi:10.1038/sj.onc.1209077.
   PubMed Web of Science ®Google Scholar
• Palmer MB, Majumder P, Cooper JC, Yoon H, Wade PA, Boss JM. Yin Yang 1 regulates the expression of snail through a distal enhancer. Mol Cancer Res. 2009;7:221–229. doi:10.1158/1541-7786.MCR-08-0229.
   PubMed Web of Science ®Google Scholar
• Zhang P, Wei Y, Wang L, Debeb BG, Yuan Y, Zhang J, Yuan J, Wang M, Chen D, Sun Y, et al. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat Cell Biol. 2014;16:864–875. doi:10.1038/ncb3013.
   PubMed Web of Science ®Google Scholar
• Zhang S, Hong Z, Chai Y, Liu Z, Du Y, Li Q, Liu Q. CSN5 promotes renal cell carcinoma metastasis and EMT by inhibiting ZEB1 degradation. Biochem Biophys Res Commun. 2017;488:101–108. doi:10.1016/j.bbrc.2017.05.016.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Zhang P, Hu X, Kim J, Yao F, Xiao Z, Zeng L, Chang L, Sun Y, Ma L. USP51 promotes deubiquitination and stabilization of ZEB1. Am J Cancer Res. 2017;7:2020–2031.
   PubMed Web of Science ®Google Scholar